RankingsPricing
  1. JP-listed companies
  2. Oncolys BioPharma Inc.

Oncolys BioPharma Inc.JP:4588

Market cap
¥12B
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023
Cash and deposits6975,5804,7273,6052,5642,8682,4633,3432,0683,4551,7111,533
Finished goods15201414131299888-
Work in process--2--5-4--13-
Supplies322222232335
Advance payments-10679531344843234506283
Prepaid expenses6511181751292032411214833
Short-term loans receivable from subsidiaries and associates-------11--40-
Accounts receivable - other212403728372417452
Income taxes refund receivable----------28-
Consumption taxes refund receivable7132923282632-95207650
Advances paid--------15-0-
Other000200110010
Current assets7315,6314,8853,6742,7473,0722,6183,8262,5464,1982,6091,956
Buildings2222131333333333
Accumulated depreciation-10-12-0-2-3-3-3-3-3-3-3-3
Buildings, net12101312--------
Machinery and equipment3830---------1
Accumulated depreciation-26-30----------1
Machinery and equipment, net11-----------
Tools, furniture and fixtures58721001036767697488656667
Accumulated depreciation-36-46-55-69-67-65-67-62-66-65-66-67
Tools, furniture and fixtures, net22264635-321221---
Property, plant and equipment46365946-321221---
Shares of subsidiaries and associates----1010101101112212121
Investments in capital000000000000
Long-term loans receivable from subsidiaries and associates-----1111-3135-43
Leasehold and guarantee deposits131437323029282821212121
Long-term prepaid expenses--22211836417-0
Other100000000000
Investments and other assets222864282394452810541229944285
Non-current assets7065124332394455812554251944285
Assets8005,6975,0094,0063,1403,5263,4304,3802,7964,2922,6512,041
Short-term borrowings6215517393639383128150239228128
Lease liabilities2510101010632348
Accounts payable - other1037414490897125320710661193
Accrued expenses61019141211121215171719
Income taxes payable8181210253336443359319
Deposits received3934534886912
Current liabilities91233263177205239212524415430322379
Long-term borrowings222343337303300344311389367256156161
Lease liabilities61529221571866719
Provision for retirement benefits223334455688
Non-current liabilities237370374328318355317402378268170188
Liabilities328603637504523594529926793698492567
Share capital2,4435,0595,0725,0725,0915,8026,4037,1217,4379,0403,0003,623
Legal capital surplus2,4355,0525,0655,0655,0835,7956,3957,1147,4299,0325861,210
Capital surplus2,4355,0525,0655,0655,0835,7956,3957,1237,4619,0645861,210
Retained earnings brought forward-4,406-5,042-5,781-6,638-7,569-8,660-9,894-10,806-12,901-14,517-1,435-3,373
Retained earnings-4,406-5,042-5,781-6,638-7,569-8,660-9,894-10,806-12,901-14,517-1,435-3,373
Treasury shares---------0-0-0-0
Shareholders' equity4725,0904,3563,4992,6052,9372,9043,4381,9963,5862,1521,459
Share acquisition rights--48211010888815
Net assets4725,0944,3713,5012,6172,9322,9013,4542,0033,5942,1591,474
Liabilities and net assets8005,6975,0094,0063,1403,5263,4304,3802,7964,2922,6512,041